Literature DB >> 29693176

PU.1 attenuates TNF‑α‑induced proliferation and cytokine release of rheumatoid arthritis fibroblast‑like synoviocytes by regulating miR‑155 activity.

Zikang Xie1, Yuxing Qu2, Pengfei Shen2, Bin Wang2, Kang Wei2, Bin Du3.   

Abstract

The present study aimed to determine the role of transcription factor PU.1 (PU.1) in tumor necrosis factor‑α (TNF‑α)‑induced proliferation and cytokine release of rheumatoid arthritis fibroblast‑like synoviocytes (RA‑FLS). It was determined that TNF‑α induced proliferation of RA‑FLS, whereas transfection with PU.1 3'untranslated region (UTR) inhibited this proliferation. Additionally, PU.1 3'UTR attenuated TNF‑α‑induced production of interleukin (IL)‑6 and IL‑1β, and downregulated the expression level of micro RNA (miR)‑155 in a dose‑dependent manner. Furthermore, transfection with PU.1 3'UTR significantly attenuated TNF‑α‑induced decrease in forkhead box protein O3 (FOXO3) expression level in RA‑FLS and these effects were consistent with the effects of miR‑155 inhibition. PU.1 and FOXO3 formed a competing endogenous RNA (ceRNA) network that regulated miR‑155 activity. In this competing endogenous RNA network, PU.1 3'UTR modulated FOXO3 expression in a miRNA‑ and 3'UTR‑dependent manner. Downregulation of FOXO3 expression reversed the PU.1 3'UTR‑mediated protective effects. Therefore, the results of the present study indicate that PU.1 3'UTR attenuates TNF‑α‑induced proliferation and cytokine release of RA‑FLS by acting as a ceRNA for FOXO3 to regulate miR‑155 activity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29693176     DOI: 10.3892/mmr.2018.8920

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  Expression profile of PU.1 in CD4+T cells from patients with systemic lupus erythematosus.

Authors:  Nan Xiang; Xuan Fang; Xiao-Ge Sun; Ying-Bo Zhou; Yan Ma; Chen Zhu; Xiang-Pei Li; Guo-Sheng Wang; Jin-Hui Tao; Xiao-Mei Li
Journal:  Clin Exp Med       Date:  2021-05-08       Impact factor: 3.984

2.  Parallel comparison of fibroblast-like synoviocytes from the surgically removed hyperplastic synovial tissues of rheumatoid arthritis and osteoarthritis patients.

Authors:  Wei Huang; Linlin Zhang; Chao Cheng; Wenshan Shan; Ruixiang Ma; Zongsheng Yin; Chen Zhu
Journal:  BMC Musculoskelet Disord       Date:  2019-12-07       Impact factor: 2.362

3.  Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts.

Authors:  Marlene Corbet; Miguel A Pineda; Kun Yang; Anuradha Tarafdar; Sarah McGrath; Rinako Nakagawa; Felicity E Lumb; Colin J Suckling; William Harnett; Margaret M Harnett
Journal:  PLoS Pathog       Date:  2021-11-08       Impact factor: 6.823

Review 4.  The role of a key transcription factor PU.1 in autoimmune diseases.

Authors:  Yilong Fang; Weile Chen; Zhe Li; Yu Chen; Xuming Wu; Xiangling Zhu; Huihui Wang; Xiaochun Chen; Qiuni Liang; Jinghua Huang; Xintong Han; Wenming Hong; Xinming Wang; Wei Wei; Zhiying Yu; Jiajie Tu
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

5.  CircRNA_09505 aggravates inflammation and joint damage in collagen-induced arthritis mice via miR-6089/AKT1/NF-κB axis.

Authors:  Jinghan Yang; Min Cheng; Bingjie Gu; Jinghua Wang; Shushan Yan; Donghua Xu
Journal:  Cell Death Dis       Date:  2020-10-07       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.